Australia markets closed

BCAL Diagnostics Limited (BDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.08000.0000 (0.00%)
At close: 11:58AM AEST
Full screen
Previous close0.0800
Bid0.0730 x N/A
Ask0.0850 x N/A
Day's range0.0750 - 0.0800
52-week range0.0590 - 0.2750
Avg. volume89,352
Market cap16.596M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.0140
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    BCAL Files Foundational Patent Application

    New lipid biomarkers central to development of breast cancer diagnostic blood test are coveredPatent application will underpin future global filings securing key features of BCAL’s test SYDNEY, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Breast cancer screening and diagnostic company BCAL Diagnostics Limited (ASX:BDX, β€˜BCAL’ or the β€˜Company’) is pleased to announce the filing of a provisional patent application number 2022901245 at IP Australia covering key lipid biomarkers that form part of its

  • Simply Wall St.

    Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...